Source BioScience offers a comprehensive portfolio of genomic services, on a variety of prominent platforms. Its capabilities include Sanger sequencing, Next-generation sequencing, Microarray analysis, Genotyping, and Bioinformatics. The company supports your research from RNA/DNA extraction, to analysis and interpretation of your data. Source BioScience's extensive product portfolio includes over 20 million clones and over 100,000 antibodies, plus a wide range of research reagents for use in applications such as cell culture, immunology, nucleic acid analysis, cloning, gene expression, and regulation.
For more information and a demo, the users can drop a request at the site and get across the demo soon.
Detailed pricing for Source Genomics has not been disclosed, but it is in line with leading competitors in the market. Pricing can be requested by connecting with a single sign-in. It gives you access to downloads, important information, and support by signing in on any device.
Sanger sequencing is a method of determining the order of events in fast turnaround times for high-quality sequencing are provided by the SpeedREAD service.
Through SpeedREAD, the Sanger Sequencing Service provides up to 1,400bp sequencing reads and automated data distribution.
For PCR products delivered at 10ng/ul, the Sanger Sequencing service produces high-quality data. The sequencing data is collected and delivered via the speedREAD service within 12 hours of receiving the sample.
Source BioScience Whole exome sequencing (WES) focuses on the protein-coding portions of the genome and is far more cost-effective than sequencing the entire genome because it only involves sequencing of 1-2 percent of the genome.
Source BioScience total RNA sequencing entails analyzing all of the RNA in a sample. By sequencing total RNA, researchers may examine not just protein-coding messenger RNA, but also non-coding RNA transcripts that may be involved in gene regulation and interference.